Clinical status of direct thrombin inhibitors

被引：9

作者：

Agnelli, G ^{[1
]}

Sonaglia, F ^{[1
]}

机构：

[1] Univ Perugia, Ist Med Interna & Med Vascolare, I-06126 Perugia, Italy

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 1999年 / 31卷 / 02期

关键词：

D O I：

10.1016/S1040-8428(99)00006-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：97 / 117

页数：21

相关论文

共 156 条

[1] AGNELLI G, 1992, THROMB HAEMOSTASIS, V67, P203
[2] AGNELLI G, 1992, BLOOD, V80, P960
[3] AGNELLI G, 1991, THROMB HAEMOSTASIS, V66, P592
[4] AGNELLI G, 1990, THROMB HAEMOSTASIS, V63, P204
[5] Alexander JH, 1996, CIRCULATION, V94, P1143
[6] Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis
Alving, BM
Krishnamurti, C
[J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (06) : 569 - 574
[7] Thrombin inhibition with inogatran for unstable angina pectoris: Evidence for reactivated ischaemia after cessation of short-term treatment
Andersen, K
Dellborg, M
Emanuelsson, H
Grip, L
Swedberg, K
[J]. CORONARY ARTERY DISEASE, 1996, 7 (09) : 673 - 681
[8] [Anonymous], 1994, Circulation, V90, P1631
[9] HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL
ANTMAN, EM
[J]. CIRCULATION, 1994, 90 (04) : 1624 - 1630
[10] Hirudin in acute myocardial infarction - Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial
Antman, EM
[J]. CIRCULATION, 1996, 94 (05) : 911 - 921

← 1 2 3 4 5 6 7 8 9 10 →